WitrynaOur lab is interested in enhancing the efficacy of cancer therapies, especially immunotherapy, by modulating cell-cell interactions. ... (CML), and TKIs are less effective against Ph+ B-cell acute ... WitrynaChronic myelogenous leukemia is a disease in which the bone marrow makes too many white blood cells. Chronic myelogenous leukemia (also called CML or chronic granulocytic leukemia) is a slowly progressing …
Immunotherapy for Acute Lymphocytic Leukemia (ALL)
Witryna30 lip 2015 · Immunotherapy provides the hope that long-term survival is achievable in a subset of patients. We hope that cures can be achieved with novel treatment approaches that include immunotherapy. Khuri: Targeted therapies have contributed more to date, but immunotherapy stands to [make] the bigger, longer-term contribution, as it … WitrynaMultifunctional nanoparticle for targeted therapeutic drug delivery, comprising (a) an iron oxide core having silica-polyethylene glycol coupled thereto to provide an iron oxide coated core, (b) a cytotoxic agent reversibly associated with the coated core; (c) an immunomodulating agent reversibly associate with the coated core; and (d) a tumor … northern milkwood
IJMS Free Full-Text Exploring the Involvement of Gut Microbiota …
WitrynaDOI: 10.1016/j.canlet.2024.216168 Corpus ID: 258037780; Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy? @article{Ghorbaninezhad2024DendriticCE, title={Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy?}, author={Farid Ghorbaninezhad … Witryna31 sie 2024 · Treatment with TKIs significantly decreases the mortality rate in patients with CML. A study by Tang et al determined that long-term TKI therapy may reduce … Witryna1 mar 2010 · Third, CML cells carry a well-defined malignancy-specific antigen, such that the immunotherapy may be effectively targeted to diseased cells [10]. Interferon alfa … how to run a bake sale